Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR

被引：5
|
作者：
van der Reijden, BA [1 ]
Massop, M [1 ]
Tönnissen, E [1 ]
van de Locht, L [1 ]
Muus, P [1 ]
de Witte, T [1 ]
Jansen, JH [1 ]
机构：
[1] Univ Nijmegen, Ctr Med, Cent Hematol Lab, NL-6500 HB Nijmegen, Netherlands
来源：
BLOOD | 2003年 / 101卷 / 12期
关键词：
D O I：
10.1182/blood-2003-02-0405
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5085 / 5086
页数：2
相关论文
共 50 条
  • [31] Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience
    Guieze, R.
    Renneville, A.
    Cayuela, J-M
    Ben Abdelali, R.
    Boissel, N.
    de Botton, S.
    Rubio, M-T
    Mazingue, F.
    Macintyre, E. A.
    Cheok, M.
    Sigaux, F.
    Fenaux, P.
    Dombret, H.
    Preudhomme, C.
    LEUKEMIA, 2010, 24 (07) : 1386 - 1388
  • [32] Clinical Implications of Cytogenetic Heterogeneity in Acute Myeloid Leukemia with inv(16)/t(16;16)/CBFB::MYH11
    Fu, Lucy
    Alvey, Emily
    Xia, Zongjun
    Sukhanova, Madina
    Aqil, Barina
    Gao, Juehua
    Ji, Peng
    Behdad, Amir
    Wolniak, Kristy
    Chen, Qing
    Chen, Yi-Hua
    Lu, Xinyan
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1135 - S1136
  • [33] Therapy-related acute myeloid leukemia with CBFB/MYH11 in a patient with ovarian cancer after exposure to chemotherapy
    Yang, Xinhong
    Liu, Qiuxia
    Zhang, Rongjuan
    Yang, Xiaofeng
    Wang, Lihong
    Zhang, Zhihua
    Li, Yan
    Lin, Li
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (04) : 865 - 867
  • [34] BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis
    Kidoguchi, Keisuke
    Kojima, Kensuke
    Yokoo, Masako
    Kimura, Shinya
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2461 - 2462
  • [35] BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis
    Keisuke Kidoguchi
    Kensuke Kojima
    Masako Yokoo
    Shinya Kimura
    Annals of Hematology, 2019, 98 : 2461 - 2462
  • [36] Prospective RT-PCR and cytogenetic analysis of 144 new cases of AML to detect PML/RARa, AML1/ETO and CBFβ/MYH11 rearrangements
    Bagshaw, J
    Vickers, SJ
    McMullan, DJ
    Bourn, D
    Waters, JJ
    Griffiths, MJ
    Davison, EV
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S28 - S28
  • [37] Prospective RT-PCR and cytogenetic analysis of 118 new cases of AML to detect PML/RARa, AML1/ETO and CBFbeta/MYH11 rearrangements
    Vickers, SJ
    Bagshaw, RJ
    McMullan, DJ
    Bourn, D
    Griffiths, MJ
    Davison, EV
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 89 - 90
  • [38] Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFβ/MYH11 RT-PCR:: Implications for a monitoring schedule and for treatment decisions
    Laczika, K
    Mitterbauer, G
    Mitterbauer, M
    Knöbl, P
    Schwarzinger, I
    Greinix, HT
    Rabitsch, W
    Fonatsch, C
    Mannhalter, C
    Lechner, K
    Jaeger, U
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 923 - 931
  • [39] Evaluation of minimal residual disease (MRD) in inv(16) positive AMLS by qualitative and quantitative RT-PCR assays of CBFb/MYH11 fusion transcripts.
    Guerrasio, A
    De Micheli, D
    Pilatrino, C
    Gottardi, E
    Serra, A
    Tessore, N
    Volpe, G
    Marmont, F
    Melillo, L
    Diverio, D
    Lo Coco, F
    Saglio, G
    BLOOD, 2000, 96 (11) : 312A - 312A
  • [40] The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB–MYH11-positive acute myeloid leukemia
    B A Van der Reijden
    M Massop
    A Simons
    T de Witte
    M Breuning
    J H Jansen
    Leukemia, 2010, 24 : 857 - 859
12345